# Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)

> **NCT05392855** · NA · TERMINATED · sponsor: **University of Missouri-Columbia** · enrollment: 6 (actual)

## Conditions studied

- Cystic Fibrosis
- Mucociliary Clearance Defect

## Interventions

- **OTHER:** Symptom driven performance of airway clearance
- **OTHER:** Continuous daily performance of airway clearance

## Key facts

- **NCT ID:** NCT05392855
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-05
- **Primary completion:** 2024-09-18
- **Final completion:** 2024-09-18
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Low recruitment, low interest from participant population
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392855, "Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05392855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*